American Journal of Microbiological Research
ISSN (Print): 2328-4129 ISSN (Online): 2328-4137 Website: https://www.sciepub.com/journal/ajmr Editor-in-chief: Apply for this position
Open Access
Journal Browser
Go
American Journal of Microbiological Research. 2025, 13(6), 130-136
DOI: 10.12691/ajmr-13-6-2
Open AccessArticle

Bacterial Ecology and Antimicrobial Resistance Patterns in the Chemotherapy Ward of CNRAO, Côte d’Ivoire: A Sub-Saharan Experience

Boni Catherine1, 2, Yapi Adompo Jaurès Cedric3, 2, , Méité Syndou3, 2, Yapi Ivanne Alexia2, Gnegouri Rachelle1, Bahan Gninissemet Armel2, Koffi Stephane2, Kacou-N’douba Adèle2 and Kouassi-M’bengue Alphonsine2

1Medical Biology Laboratory, Alassane Ouattara National Centre for Medical Oncology and Radiotherapy (CNRAO), Abidjan, Côte d’Ivoire

2Microbiology Teaching Unit, Faculty of Medical Sciences, Felix Houphouët Boigny University, Abidjan, Côte d’Ivoire

3Bacteriology-Virology Laboratory, Yopougon University Hospital, Abidjan, Côte d’Ivoire

Pub. Date: December 04, 2025

Cite this paper:
Boni Catherine, Yapi Adompo Jaurès Cedric, Méité Syndou, Yapi Ivanne Alexia, Gnegouri Rachelle, Bahan Gninissemet Armel, Koffi Stephane, Kacou-N’douba Adèle and Kouassi-M’bengue Alphonsine. Bacterial Ecology and Antimicrobial Resistance Patterns in the Chemotherapy Ward of CNRAO, Côte d’Ivoire: A Sub-Saharan Experience. American Journal of Microbiological Research. 2025; 13(6):130-136. doi: 10.12691/ajmr-13-6-2

Abstract

Background: Cancer patients receiving chemotherapy are highly vulnerable to environmental infections due to treatment-induced immunosuppression, yet bacterial contamination and antibiotic resistance patterns in African oncology facilities remain uncharacterized. We conducted a comprehensive environmental surveillance of a West African chemotherapy unit to identify infection risks threatening these vulnerable patients. Methods: We collected 39 environmental samples (36 surfaces, 3 air) from high-touch sites across the chemotherapy unit at Centre National de Radiothérapie et d'Oncologie Médicale Alassane Ouattara (August-October 2024). Bacterial isolates underwent identification using conventional methods and API systems, with antimicrobial susceptibility testing by Kirby-Bauer disk diffusion under EUCAST 2023 guidelines. Extended-spectrum β-lactamase (ESBL) production was confirmed by double-disk synergy testing. Results: Surface contamination occurred in 63.9% of samples; air remained sterile. Twenty-nine isolates recovered: Bacillus spp. (34.5%), coagulase-negative staphylococci (27.6%), Pseudomonas aeruginosa (20.7%), Enterobacteriaceae (17.2%). Water sources harbored Pseudomonas and ESBL-producers. Resistance was substantial: 40% Enterobacteriaceae produced ESBLs with fluoroquinolone co-resistance, 14.3% coagulase-negative staphylococci exhibited methicillin/aminoglycoside resistance, all P. aeruginosa (6/6) showed intermediate colistin susceptibility. Bacillus demonstrated aminopenicillin resistance but carbapenem susceptibility. No carbapenemase-producers detected. Conclusions: This chemotherapy unit surveillance reveals concerning environmental contamination with resistant opportunistic pathogens. Bacillus predominance and water-associated Pseudomonas/ESBL-Enterobacteriaceae colonization highlight unique tropical ecology patterns. Enhanced cleaning protocols, water system management, and antimicrobial stewardship adapted to local resistance are urgently needed. These baseline data inform infection prevention programs protecting vulnerable African cancer patients.

Keywords:
Antimicrobial resistance Environmental surveillance Healthcare-associated infections Sub-Saharan Africa Côte d’Ivoire

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  World Health Organization. Report on the Burden of Endemic Health Care-Associated Infection Worldwide. Geneva: WHO; 2011. PDF disponible: https:// apps.who.int/ iris/bitstream/ handle/10665/80135/9789241501507_eng.pdf?sequence=1.
 
[2]  Burden of endemic healthcareassociated infection in developing countries: systematic review and metaanalysis – B Allegranzi et al. Lancet. 2011;377(9761):228-241. PDF: https:// www. thelancet.com/ journals/ lancet/article /PIIS0140-6736(10) 61458-4/fulltext.
 
[3]  Donskey CJ. Does improving surface cleaning and disinfection reduce health care–associated infections? Am J Infect Control. 2013; 41(5 Suppl): S12–9.
 
[4]  Otter JA, Yezli S, French GL. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol. 2011; 32(7): 687–699.
 
[5]  Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis. 2013; 26(4): 338–344.
 
[6]  Lax S, Gilbert JA. Hospital-associated microbiota and implications for nosocomial infections. Trends Mol Med. 2015; 21(7): 427–432.
 
[7]  Brooks B, Firek BA, Miller CS, Sharon I, Thomas BC, Baker R, Morowitz MJ, Banfield JF. Microbes in the neonatal intensive care unit resemble those found in the gut of premature infants. Microbiome. 2014 Jan 28; 2(1): 1.
 
[8]  Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. J Clin Oncol. 2018; 36(30): 3043–3054.
 
[9]  Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett EE. Role of hospital surfaces in the transmission of emerging health care–associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control. 2010; 38(5 Suppl 1): S25–33.
 
[10]  Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect. 2007; 65 Suppl 2: 50–54.
 
[11]  Irek EO, Amupitan AA, Obadare TO & Aboderin AO. A systematic review of healthcare-associated infections in Africa: An antimicrobial resistance perspective Afr J Lab Med. 2018; 7(2), a796.
 
[12]  Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLOS One. 2017; 17(1): 577.
 
[13]  Méité S, Boni-Cissé C, Monemo P, Mlantanoa AP, Faye-ketté H, Dosso H. Surveillance microbiologique des surfaces au niveau d’un établissement hospitalier de niveau tertiaire: exemple du CHU de Yopougon (Abidjan,Côte d’Ivoire). J Sci Pharm Biol 2010; 11(1): 73—81
 
[14]  Samira B, Soraya B, Zahia H. Assessment of hospital environmental bacterial contamination in the western region of Algeria. Asian Pacific Journal of Tropical Disease. 2015; 5(6): 436-440.
 
[15]  Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2011; 52(4): e56-e93.
 
[16]  Napoli C, Marcotrigiano V, Montagna MT. Air sampling procedures to evaluate microbial contamination: a comparison between active and passive methods in operating theatres. BMC Public Health. 2012; 12: 594.
 
[17]  Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med. 2010 May 13; 362(19): 1804-13.
 
[18]  Andrianjafy TM, Rasamindrakotroka MT, Henintsoa RN, et al. Bacterial contamination of medical devices and the hospital environment in the intensive care unit at the University Hospital in Antananarivo, Madagascar. Journal of Infection in Developing Countries. 2017; 11(8): 623-628.
 
[19]  Barbosa TM, Serra CR, La Ragione RM, Woodward MJ, Henriques AO. Screening for Bacillus isolates in the broiler gastrointestinal tract. Applied and Environmental Microbiology. 2005; 71(2): 968-978.
 
[20]  Bottone EJ. Bacillus cereus, a volatile human pathogen. Clinical Microbiology Reviews. 2010; 23(2): 382-398.
 
[21]  Loveday HP, Wilson JA, Kerr K, et al. Association between healthcare water systems and Pseudomonas aeruginosa infections: a rapid systematic review. Journal of Hospital Infection. 2014; 86(1): 7-15.
 
[22]  Russotto V, Cortegiani A, Raineri SM, Giarratano A. Bacterial contamination of inanimate surfaces and equipment in the intensive care unit. Journal of Intensive Care. 2015; 3: 54.
 
[23]  Kizny Gordon AE, Mathers AJ, Cheong EYL, et al. The hospital water environment as a reservoir for carbapenem-resistant organisms causing hospital-acquired infections—a systematic review of the literature. Clinical Infectious Diseases. 2017; 64(10): 1435-1444.
 
[24]  Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clinical Microbiology Reviews. 2014;27(4):870-926.
 
[25]  Favre B, Hugonnet S, Correa L, Sax H, Rohner P, Pittet D. Nosocomial bacteremia: clinical significance of a single blood culture positive for coagulase-negative staphylococci. Infection Control and Hospital Epidemiology. 2005; 26(8): 697-702.
 
[26]  Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy. 2007; 60(5): 913-920.
 
[27]  Kotay S, Chai W, Guilford W, Barry K, Mathers AJ. Spread from the sink to the patient: in situ study using green fluorescent protein (GFP)-expressing Escherichia coli to model bacterial dispersion from hand-washing sink-trap reservoirs. Applied and Environmental Microbiology. 2017; 83(8): e03327-16.
 
[28]  Leitner E, Zarfel G, Luxner J, et al. Contaminated handwashing sinks as the source of a clonal outbreak of KPC-2-producing Klebsiella oxytoca on a hematology ward. Antimicrobial Agents and Chemotherapy. 2015; 59(1): 714-716.
 
[29]  Li, N., Siddique, A., Liu, N., Teng, L., Ed-Dra, A., Yue, M., & Li, Y. (2025). Global Epidemiology and health risks of Bacillus cereus Infections: Special focus on infant foods. Food research international (Ottawa, Ont.), 201, 115650.